Hotchkis & Wiley Capital Management
TBI

Hotchkis & Wiley Capital Management’s Trueblue TBI Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.59M Buy
1,430,215
+30,650
+2% +$136K 0.02% 376
2025
Q4 		$6.37M Buy
1,399,565
+137,070
+11% +$703K 0.02% 365
2025
Q3 		$7.74M Sell
1,262,495
-45,495
-3% -$288K 0.02% 301
2025
Q2 		$8.48M Buy
1,307,990
+307,660
+31% +$1.66M 0.03% 298
2025
Q1 		$5.31M Sell
1,000,330
-11,640
-1% -$79.5K 0.02% 376
2024
Q4 		$8.5M Sell
1,011,970
-99,840
-9% -$771K 0.03% 295
2024
Q3 		$8.77M Sell
1,111,810
-5,260
-0.5% -$47.3K 0.03% 272
2024
Q2 		$11.5M Buy
1,117,070
+190,320
+21% +$2.06M 0.04% 208
2024
Q1 		$11.6M Buy
926,750
+116,100
+14% +$1.5M 0.04% 211
2023
Q4 		$12.4M Sell
810,650
-1,874,200
-70% -$26.2M 0.04% 163
2023
Q3 		$39.4M Buy
2,684,850
+126,890
+5% +$1.98M 0.15% 103
2023
Q2 		$45.3M Buy
2,557,960
+47,410
+2% +$804K 0.17% 93
2023
Q1 		$44.7M Buy
2,510,550
+41,580
+2% +$777K 0.17% 92
2022
Q4 		$48.3M Buy
2,468,970
+48,680
+2% +$987K 0.19% 89
2022
Q3 		$46.2M Sell
2,420,290
-24,400
-1% -$494K 0.2% 85
2022
Q2 		$43.8M Buy
2,444,690
+347,310
+17% +$8.15M 0.17% 80
2022
Q1 		$60.6M Buy
2,097,380
+216,120
+11% +$5.94M 0.19% 86
2021
Q4 		$52.1M Buy
1,881,260
+583,700
+45% +$16.5M 0.16% 88
2021
Q3 		$35.1M Buy
1,297,560
+953,460
+277% +$25.5M 0.11% 100
2021
Q2 		$9.67M Sell
344,100
-55,460
-14% -$1.48M 0.03% 150
2021
Q1 		$8.8M Buy
399,560
+25,030
+7% +$513K 0.03% 148
2020
Q4 		$7M Buy
374,530
+65,800
+21% +$1.18M 0.02% 180
2020
Q3 		$4.78M Buy
308,730
+17,720
+6% +$273K 0.02% 179
2020
Q2 		$4.44M Sell
291,010
-14,890
-5% -$221K 0.02% 216
2020
Q1 		$3.9M Buy
305,900
+82,720
+37% +$1.48M 0.02% 209
2019
Q4 		$5.37M Buy
223,180
+91,990
+70% +$2.1M 0.02% 270
2019
Q3 		$2.77M Buy
131,190
+4,140
+3% +$85.6K 0.01% 368
2019
Q2 		$2.8M Buy
+127,050
New +$2.95M 0.01% 356

Other funds holding TBI

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hotchkis & Wiley Capital Management's TBI Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management increased its Trueblue (TBI) stake by 2.2% in Q1 2026, buying an estimated $136K and bringing the position to 1,430,215 shares worth $5.59M. The position accounts for 0.02% of the portfolio, ranked #376.

Hotchkis & Wiley Capital Management first reported a position in TBI in Q2 2019 and has held it in 28 quarters since. The position peaked at $60.6M in Q1 2022. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Hotchkis & Wiley Capital Management held 1,430,215 shares of Trueblue worth $5.59M as of Q1 2026.
  • Hotchkis & Wiley Capital Management bought 30,650 Trueblue shares in Q1 2026, an estimated $136K.
  • Trueblue made up 0.02% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #376 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Trueblue in Q2 2019 and has held it in 28 quarters since.
  • Hotchkis & Wiley Capital Management's Trueblue position peaked at $60.6M in Q1 2022.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.